Pharmaco–Vigilance from A to Z: Adverse Drug Event Surveillance

Pharmacovigilance, the study of the adverse drug reactions which appear during a product′s normal use for therapeutic purposes, is fast gaining the attention of the medical community. Aimed primarily at making drugs safer and improving durg surveillance, pharmacovigilance is currently a field of premier importance.
Pharmacovigilance from A to Z provides a table of contents for use as a textbook of all vital aspects of this fast–growing field. The alphabetized work provides the reader with information about the concepts, terms, methods, tools, definitions, and issues in pharmacovigilance. The referenced websites provide links to the changing information, such as local and international harmonization initiatives, changes in regulation, and new techniques.
This handbook is aimed not only at professors and students in the academic setting, but also at newcomers to the field of pharmacovigilance who must learn on their own the basics of this complex field.

Spis treści:
Foreword.
Introduction.
Abbreviations.
A.
B.
C.
D.
E.
F.
G.
H.
I.
JKL.
M.
N.
O.
PQ.
R.
S.
T.
U.
V.
W.
XYZ.

Okładka tylna:
Pharmacovigilance, the study of the adverse drug reactions which appear during a product′s normal use for therapeutic purposes, is fast gaining the attention of the medical community. Aimed primarily at making drugs safer and improving durg surveillance, pharmacovigilance is currently a field of premier importance.
Pharmacovigilance from A to Z provides a table of contents for use as a textbook of all vital aspects of this fast–growing field. The alphabetized work provides the reader with information about the concepts, terms, methods, tools, definitions, and issues in pharmacovigilance. The referenced websites provide links to the changing information, such as local and international harmonization initiatives, changes in regula tion, and new techniques.
This handbook is aimed not only at professors and students in the academic setting, but also at newcomers to the field of pharmacovigilance who must learn on their own the basics of this complex field.